CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Sold out
In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.
- Q4 2020: Stock OMEROS CORP; Country of operation —; Class NOTE 6.250%11/1; Principal before $17,730,000.
- Q4 2020: Stock TPG SPECIALTY LENDING INC; Country of operation —; Class NOTE 4.500% 8/0; Principal before $16,300,000.
- Q4 2020: Stock COWEN INC; Country of operation —; Class NOTE 3.000%12/1; Principal before $15,181,000.
- Q4 2020: Stock ENCORE CAP EUROPE FIN LTD; Country of operation —; Class NOTE 4.500% 9/0; Principal before $15,000,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Principal before | Principal after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q4 2020 | OMEROS CORP
CUSIP 682143AE2 | — | NOTE 6.250%11/1 | $17,730,000 | $0 | -17,730,000 | $16,836 | $0 | -$16,836 | 2021-02-16 |
|---|
| Q4 2020 | TPG SPECIALTY LENDING INC
CUSIP 87265KAD4 | — | NOTE 4.500% 8/0 | $16,300,000 | $0 | -16,300,000 | $16,773 | $0 | -$16,773 | 2021-02-16 |
|---|
| Q4 2020 | COWEN INC
CUSIP 223622AE1 | — | NOTE 3.000%12/1 | $15,181,000 | $0 | -15,181,000 | $16,548 | $0 | -$16,548 | 2021-02-16 |
|---|
| Q4 2020 | ENCORE CAP EUROPE FIN LTD
CUSIP 29260UAA5 | — | NOTE 4.500% 9/0 | $15,000,000 | $0 | -15,000,000 | $16,406 | $0 | -$16,406 | 2021-02-16 |
|---|
| Q4 2020 | MAGNACHIP SEMICONDUCTOR SA
CUSIP 55932XAB0 | — | NOTE 5.000% 3/0 | $9,530,000 | $0 | -9,530,000 | $16,082 | $0 | -$16,082 | 2021-02-16 |
|---|
| Q4 2020 | TIMKENSTEEL CORP
CUSIP 887399AA1 | — | NOTE 6.000% 6/0 | $18,500,000 | $0 | -18,500,000 | $15,925 | $0 | -$15,925 | 2021-02-16 |
|---|
| Q4 2020 | ALTERYX INC
CUSIP 02156BAB9 | — | NOTE 0.500% 6/0 | $6,052,000 | $0 | -6,052,000 | $15,895 | $0 | -$15,895 | 2021-02-16 |
|---|
| Q4 2020 | INNOVIVA INC
CUSIP 45781MAB7 | — | NOTE 2.500% 8/1 | $16,219,000 | $0 | -16,219,000 | $15,802 | $0 | -$15,802 | 2021-02-16 |
|---|
| Q4 2020 | RETROPHIN INC
CUSIP 761299AB2 | — | NOTE 2.500% 9/1 | $18,500,000 | $0 | -18,500,000 | $15,793 | $0 | -$15,793 | 2021-02-16 |
|---|
| Q4 2020 | INPHI CORP
CUSIP 45772FAC1 | — | NOTE 0.750% 9/0 | $7,588,000 | $0 | -7,588,000 | $15,231 | $0 | -$15,231 | 2021-02-16 |
|---|
| Q4 2020 | LIVE NATION ENTERTAINMENT IN
CUSIP 538034AQ2 | — | NOTE 2.500% 3/1 | $12,539,000 | $0 | -12,539,000 | $13,959 | $0 | -$13,959 | 2021-02-16 |
|---|
| Q4 2020 | INCYTE CORP
CUSIP 45337CAN2 | — | NOTE 1.250%11/1 | $7,716,000 | $0 | -7,716,000 | $13,393 | $0 | -$13,393 | 2021-02-16 |
|---|
| Q4 2020 | CHIMERA INVT CORP
CUSIP 16934QAA7 | — | NOTE 7.000% 4/0 | $10,000,000 | $0 | -10,000,000 | $12,617 | $0 | -$12,617 | 2021-02-16 |
|---|
| Q4 2020 | GSV CAP CORP
CUSIP 36191JAC5 | — | NOTE 4.750% 3/2 | $11,000,000 | $0 | -11,000,000 | $12,540 | $0 | -$12,540 | 2021-02-16 |
|---|
| Q4 2020 | CALAMP CORP
CUSIP 128126AD1 | — | NOTE 2.000% 8/0 | $15,000,000 | $0 | -15,000,000 | $12,304 | $0 | -$12,304 | 2021-02-16 |
|---|
| Q4 2020 | VISHAY INTERTECHNOLOGY INC
CUSIP 928298AP3 | — | NOTE 2.250% 6/1 | $12,000,000 | $0 | -12,000,000 | $11,640 | $0 | -$11,640 | 2021-02-16 |
|---|
| Q4 2020 | VIAVI SOLUTIONS INC
CUSIP 925550AE5 | — | NOTE 1.750% 6/0 | $10,029,000 | $0 | -10,029,000 | $11,155 | $0 | -$11,155 | 2021-02-16 |
|---|
| Q4 2020 | SEACOR HOLDINGS INC
CUSIP 811904AN1 | — | NOTE 3.250% 5/1 | $14,642,000 | $0 | -14,642,000 | $11,114 | $0 | -$11,114 | 2021-02-16 |
|---|
| Q4 2020 | HELIX ENERGY SOLUTIONS GRP I
CUSIP 42330PAK3 | — | NOTE 6.750% 2/1 | $13,500,000 | $0 | -13,500,000 | $10,951 | $0 | -$10,951 | 2021-02-16 |
|---|
| Q4 2020 | HERITAGE INS HLDGS INC
CUSIP 42727JAB8 | — | NOTE 5.875% 8/0 | $10,663,000 | $0 | -10,663,000 | $10,728 | $0 | -$10,728 | 2021-02-16 |
|---|
| Q4 2020 | TILRAY INC
CUSIP 88688TAB6 | — | NOTE 5.000%10/0 | $24,990,000 | $0 | -24,990,000 | $10,320 | $0 | -$10,320 | 2021-02-16 |
|---|
| Q4 2020 | THERAVANCE INC
CUSIP 88338TAB0 | — | NOTE 2.125% 1/1 | $10,750,000 | $0 | -10,750,000 | $10,301 | $0 | -$10,301 | 2021-02-16 |
|---|
| Q4 2020 | BLACKLINE INC
CUSIP 09239BAB5 | — | NOTE 0.125% 8/0 | $7,000,000 | $0 | -7,000,000 | $9,644 | $0 | -$9,644 | 2021-02-16 |
|---|
| Q4 2020 | VEONEER INC
CUSIP 92336XAA7 | — | NOTE 4.000% 6/0 | $9,500,000 | $0 | -9,500,000 | $9,341 | $0 | -$9,341 | 2021-02-16 |
|---|
| Q4 2020 | IQIYI INC
CUSIP 46267XAB4 | — | NOTE 3.750%12/0 | $8,000,000 | $0 | -8,000,000 | $8,520 | $0 | -$8,520 | 2021-02-16 |
|---|
| Q4 2020 | CSG SYS INTL INC
CUSIP 126349AF6 | — | NOTE 4.250% 3/1 | $7,926,000 | $0 | -7,926,000 | $8,240 | $0 | -$8,240 | 2021-02-16 |
|---|
| Q4 2020 | KAMAN CORP
CUSIP 483548AF0 | — | NOTE 3.250% 5/0 | $6,600,000 | $0 | -6,600,000 | $6,517 | $0 | -$6,517 | 2021-02-16 |
|---|
| Q4 2020 | PACIRA BIOSCIENCES
CUSIP 695127AD2 | — | NOTE 2.375% 4/0 | $5,572,000 | $0 | -5,572,000 | $6,389 | $0 | -$6,389 | 2021-02-16 |
|---|
| Q4 2020 | SEACOR HOLDINGS INC
CUSIP 811904AM3 | — | NOTE 2.500%12/1 | $7,110,000 | $0 | -7,110,000 | $6,312 | $0 | -$6,312 | 2021-02-16 |
|---|
| Q4 2020 | MOMO INC
CUSIP 60879BAB3 | — | NOTE 1.250% 7/0 | $8,000,000 | $0 | -8,000,000 | $6,281 | $0 | -$6,281 | 2021-02-16 |
|---|
| Q4 2020 | XERIS PHARMACEUTICALS INC
CUSIP 98422LAA5 | — | NOTE 5.000% 7/1 | $3,000,000 | $0 | -3,000,000 | $5,846 | $0 | -$5,846 | 2021-02-16 |
|---|
| Q4 2020 | OPKO HEALTH INC
CUSIP 68375NAD5 | — | NOTE 4.500% 2/1 | $4,550,000 | $0 | -4,550,000 | $5,396 | $0 | -$5,396 | 2021-02-16 |
|---|
| Q4 2020 | APELLIS PHARMACEUTICALS INC
CUSIP 03753UAB2 | — | NOTE 3.500% 9/1 | $4,500,000 | $0 | -4,500,000 | $4,865 | $0 | -$4,865 | 2021-02-16 |
|---|
| Q4 2020 | ZENDESK INC
CUSIP 98936JAB7 | — | NOTE 0.250% 3/1 | $2,109,000 | $0 | -2,109,000 | $3,616 | $0 | -$3,616 | 2021-02-16 |
|---|
| Q4 2020 | PTC THERAPEUTICS INC
CUSIP 69366JAB7 | — | NOTE 3.000% 8/1 | $3,000,000 | $0 | -3,000,000 | $3,409 | $0 | -$3,409 | 2021-02-16 |
|---|
| Q4 2020 | MERITOR INC
CUSIP 59001KAC4 | — | NOTE 7.875% 3/0 | $1,784,000 | $0 | -1,784,000 | $3,145 | $0 | -$3,145 | 2021-02-16 |
|---|
| Q4 2020 | NEVRO CORP
CUSIP 64157FAA1 | — | NOTE 1.750% 6/0 | $1,810,000 | $0 | -1,810,000 | $2,715 | $0 | -$2,715 | 2021-02-16 |
|---|
| Q4 2020 | ALTAIR ENGR INC
CUSIP 021369AA1 | — | NOTE 0.250% 6/0 | $2,000,000 | $0 | -2,000,000 | $2,220 | $0 | -$2,220 | 2021-02-16 |
|---|
| Q4 2020 | JAZZ INVESTMENTS I LTD
CUSIP 472145AD3 | — | NOTE 1.500% 8/1 | $2,000,000 | $0 | -2,000,000 | $2,029 | $0 | -$2,029 | 2021-02-16 |
|---|
| Q4 2020 | ALTERYX INC
CUSIP 02156BAD5 | — | NOTE 0.500% 8/0 | $2,000,000 | $0 | -2,000,000 | $2,003 | $0 | -$2,003 | 2021-02-16 |
|---|